Health News Releases

  • Today February 18
June 17, 2016 13:05
QUINTILES RECOGNIZED AS INDUSTRY LEADER FOR PHASE I, PHASE II/III AND PHASE IV SERVICES
Quintiles has been named the industry leader in Phase I, Phase II/III and Phase IV services, according to the Industry Standard Research’s (ISR) 2016 CRO Quality Benchmarking — Phases I, II/III and IV
June 16, 2016 14:00
Patient Safety Movement Announces Three New Patient Safety Challenges
The Patient Safety Movement Foundation announced three new patient safety challenges at its Midyear Planning Meeting co-convened with Inova. The 2016 Midyear Planning Meeting brought together over 100
June 15, 2016 15:55
Landmark Study Suggests Cranberries Can Decrease Use of Antibiotics
Today leading experts on infectious disease and urinary tract infections (UTIs) will gather in London to discuss the alarming state of antibiotic resistance and present findings from a landmark study
June 15, 2016 11:45
Jardiance® (empagliflozin) significantly reduced the risk of progressive kidney disease in adults with type 2 diabetes with established cardiovascular disease
New data showed Jardiance® (empagliflozin) reduced the risk for new-onset or worsening kidney disease by 39 percent versus placebo when added to standard of care in people with type 2 diabetes with es
June 13, 2016 11:50
New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
New analyses showed risk reductions were consistent across age groups for cardiovascular (CV) outcomes, including CV death, with Jardiance® (empagliflozin) compared with placebo when added to standard
June 13, 2016 10:50
New study results show Trajenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment
Results from the MARLINA-T2DTM trial demonstrated that Trajenta® (linagliptin), which is marketed by Boehringer Ingelheim and Eli Lilly and Company, reduced blood sugar in adults with type 2 diabetes
June 10, 2016 18:00
Menarini Group and MSD Extends Global Partnership to the Asia-Pacific Region
Singapore-based A. Menarini Asia-Pacific Holdings Pte Ltd (“Menarini Asia-Pacific”) and MSD have embarked on a multi-year partnership for Menarini Asia-Pacific to assume the sales, marketing and distr
June 10, 2016 16:40
Masimo Announces Full Market Release of Next Generation SpHb® Spot Check Pronto®
Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto® Pulse CO-Oximeter® with Next Generation SpHb® Spot Check technology. Next Generation Pronto features rainb
June 10, 2016 13:25
TAGRISSO (OSIMERTINIB) SHOWS CLINICAL ACTIVITY IN PATIENTS WITH LEPTOMENINGEAL DISEASE FROM LUNG CANCER
AstraZeneca today announced clinical and safety data for Tagrisso (osimertinib) in patients with leptomeningeal (LM) disease, a complication of epidermal growth factor receptor (EGFR) mutation-positiv
June 10, 2016 10:50
Lynparza (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer
AstraZeneca today presented results from a third interim analysis of Study 19 that suggest an improvement in overall survival (OS) for patients with ovarian cancer treated with Lynparza (olaparib) mai
June 09, 2016 18:15
DURVALUMAB MONOTHERAPY DEMONSTRATES EFFICACY IN UROTHELIAL BLADDER CANCER
AstraZeneca and its global biologics research and development arm, MedImmune, today announced efficacy and safety data for durvalumab, a selective programmed-death ligand-1 (PD-L1) antibody, in patien
June 09, 2016 16:00
Ascensia Diabetes Care Renews International Alliance with Medtronic
Today Ascensia Diabetes Care announced that it has renewed its global alliance with Medtronic plc to develop and market innovative diabetes management solutions for patients worldwide. As part of the
June 09, 2016 14:00
Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide
W. L. Gore & Associates (Gore) today announced the GORE® TAG® Thoracic Device family has exceeded 100,000 devices distributed worldwide. Built on more than 18 years of success in both clinical studies
June 09, 2016 09:45
European Society of Anaesthesiology Partners with Patient Safety Movement to Lead the Movement to Zero Preventable Deaths in Europe
The European Society of Anaesthesiology (ESA) and the Patient Safety Movement Foundation announced today that on May 28, 2016 at the annual congress Euroanaesthesia 2016 in London, the ESA made a publ
June 09, 2016 09:15
Samsung Bioepis Announces New Data on Three Anti-TNF-α Biosimilar Molecules at the Annual European Congress on Rheumatology (EULAR 2016)
Samsung Bioepis Co., Ltd. today announced new clinical data on its anti-TNF-α portfolio of Benepali® (etanercept), Flixabi® (infliximab) and SB5 (adalimumab) investigational biosimilar candidate. The
June 08, 2016 18:00
Data Presented at ASCO 2016 Builds upon Foundation of Abraxane® Plus Gemcitabine as a First-Line Treatment in Patients with Metastatic Pancreatic Cancer
Celgene Corporation (NASDAQ:CELG) today announced that results from multiple sponsored and independent studies presented during the 52nd ASCO Annual Meeting evaluated the use of ABRAXANE® (paclitaxel
June 08, 2016 17:20
Pooled Data from Meta-Analysis Suggest Significant Overall Survival Benefit of Investigational REVLIMID® Maintenance Following Autologous Stem Cell Transplant in Multiple Myeloma
Celgene Corporation (NASDAQ:CELG) today announced data from a meta-analysis of overall survival in multiple myeloma (MM) patients receiving investigational maintenance treatment with REVLIMID® (lenali
June 08, 2016 13:45
Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
W. L. Gore & Associates, Inc. (Gore) today announced completion of enrollment into its early feasibility study evaluating the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) for the tre
June 08, 2016 11:15
Win a Fishing Trip with President Jimmy Carter by Committing to Zero Preventable Deaths by 2020
The Patient Safety Movement announced today that for the 2nd year in a row, former President Carter is demonstrating his support for the Movement’s goal of zero preventable deaths by 2020 by offering
June 08, 2016 09:55
Boehringer Ingelheim and Harvard scientists establish a research alliance to find novel treatments for severe fibrotic diseases
Boehringer Ingelheim today announced it has established a research collaboration with the Harvard Stem Cell Institute’s - Harvard Fibrosis Network to discover new ways of treating fibrotic diseases su
June 07, 2016 11:45
New data on olmutinib (BI 1482694) presented at ASCO 2016 underscores clinical potential of Boehringer Ingelheim’s next generation lung cancer compound
Boehringer Ingelheim will announce updated results from the Phase II part of the HM-EMSI-101 [NCT01588145] trial at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, U
June 03, 2016 17:45
Herbalife Returns as Title Sponsor of Bali International Triathlon 2016
Herbalife, a global nutrition company (NYSE: HLF), announced today that it has become the title sponsor of the Bali International Triathlon 2016. Now officially named the Herbalife Bali International
June 03, 2016 14:20
Quintiles Introduces Precision Enrollment to Enhance Patient Recruitment in Oncology Trials
Quintiles, the world’s largest provider of product development and integrated healthcare services, today announced its Precision Enrollment offering. The new enrollment model is designed to significan
June 03, 2016 13:30
One of India’s Premier Maternal Care Specialists, Motherhood Hospitals, Standardizes on Masimo SET® Technology
Masimo (NASDAQ: MASI) announced today that Motherhood Hospitals, a maternal care specialist with five hospitals in three cities in India, has standardized on Masimo SET® (Signal Extraction Technology)
June 03, 2016 13:15
GORE® EXCLUDER® Conformable AAA Endoprosthesis Obtains CE Mark
W. L. Gore & Associates, Inc. (Gore) today announced receipt of CE Mark for the GORE® EXCLUDER® Conformable AAA Device, a product designed for the treatment of abdominal aortic aneurysms (AAA) in pati
25 per page50 per page75 per page100 per page